Maia M.C. Bennett-Boehm
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maia M.C. Bennett-Boehm has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Alexander K. Regan
Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska, USA
1 shared publication- Alexander T. Heubeck
Allen Institute for Immunology, Seattle, WA, USA
1 shared publication Angela N. Truong
Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska, USA
1 shared publication- Anna R. Mahr
Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska, USA
1 shared publication - Arriana Blackmon
Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska, USA
1 shared publication Bella A. Circo
Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska, USA
1 shared publication
Latest Publications
- Open Access
- 21 August 2026
- Published by Wiley in Cytometry Part A
- Vol. 109 (9) , 635-648
High‐Dimensional Spectral Flow Cytometry Panel for Immunophenotypic Characterization of Fixed Whole Blood Samples
Peripheral blood mononuclear cells (PBMCs) are commonly used for immune profiling in clinical research, but their isolation and cryopreservation present logistical challenges, particularly in settings with limited access to research facilities. To address this, we implemented a whole blood fixation protocol to preserve surface protein epitopes and enable high‐dimensional flow cytometry without the need for immediate sample processing. A 36‐marker lymphoid and 35‐marker myeloid spectral flow cytometry panels were developed and optimized to characterize diverse immune populations, including T cell subsets, B cells, NK cells, monocytes, dendritic cells, and granulocytes. Panel design focused on antibody clone compatibility with fixed antigens, minimizing non‐specific binding, and reliably detecting chemokine receptors. Performance was evaluated by comparing fresh and fixed whole blood, revealing consistent identification of major immune lineages. Long‐term stability was demonstrated by using cryopreserved fixed blood from a healthy donor over two and half years, with immune profiles remaining stable. These findings support the use of fixed whole blood for high‐dimensional spectral cytometry and its utility in longitudinal clinical immune monitoring.
- 21 August 2026
- Published by Wiley in Cytometry Part A
- Vol. 109 (9) , 635-648
Open AccessHigh‐Dimensional Spectral Flow Cytometry Panel for Immunophenotypic Characterization of Fixed Whole Blood Samples
Peripheral blood mononuclear cells (PBMCs) are commonly used for immune profiling in clinical research, but their isolation and cryopreservation present logistical challenges, particularly in settings with limited access to research facilities. To address this, we implemented a whole blood fixation protocol to preserve surface protein epitopes and enable high‐dimensional flow cytometry without the need for immediate sample processing. A 36‐marker lymphoid and 35‐marker myeloid spectral flow cytometry panels were developed and optimized to characterize diverse immune populations, including T cell subsets, B cells, NK cells, monocytes, dendritic cells, and granulocytes. Panel design focused on antibody clone compatibility with fixed antigens, minimizing non‐specific binding, and reliably detecting chemokine receptors. Performance was evaluated by comparing fresh and fixed whole blood, revealing consistent identification of major immune lineages. Long‐term stability was demonstrated by using cryopreserved fixed blood from a healthy donor over two and half years, with immune profiles remaining stable. These findings support the use of fixed whole blood for high‐dimensional spectral cytometry and its utility in longitudinal clinical immune monitoring.
- Open Access
Development and implementation of natural killer cell simultaneous ADCC and direct killing assay